Hagens, Eliza R. C.
Künzli, Hannah T.
van Rijswijk, Anne-Sophie
Meijer, Sybren L.
Mijnals, R. Clinton D.
Weusten, Bas L. A. M.
Geijsen, E. Debby
van Laarhoven, Hanneke W. M.
van Berge Henegouwen, Mark I.
Gisbertz, Suzanne S.
Article History
Received: 14 May 2019
Accepted: 9 October 2019
First Online: 17 October 2019
Compliance with ethical standards
:
: Drs Hagens, Künzli, van Rijswijk, Meijer, Mijnals, Geijsen, and Gisbertz have no conflicts of interest of financial ties to disclose. van Berge Henegouwen has served as consultant for Medtronic and has received unrestricted research funding from Olympus and Stryker. Hanneke W. M. van Laarhoven has served as a consultant for BMS, Celgene, Lilly, and Nordic and has received unrestricted research funding from Bayer, Celgene, Lilly, Merck Serono, MSD, Nordic, Philips, and Roche. Bas Weusten received research support for IRB approved studies from GI Solutions Covidien, Erbe, and C2 Therapeutics. He received a honorarium consultancy speakers fee of Boston Scientific and C2Therapeutics.